Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Biocartis Group NV (BCART)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.29 0.00    0.00%
31/12 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Belgium
ISIN:  BE0974281132 
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 0.29 - 0.29
Biocartis Group NV 0.29 0.00 0.00%

BCART User Rankings

 
Users ranking according to the performance of their sentiments for the Biocartis Group NV stock.
RankUsernameTotalClosedWinningWin %Chg. %
1Clement Coenen43266.67+44.6%
2Willem Peeters111100+28.43%
3alexis mathieu111100+26.24%
4Philippe Troch211100+20.54%
5Ferre Acx22150+18.44%
6Sven De Waelheyns111100+18.43%
7kadri cela111100+17.87%
8Jorg Elst111100+17.41%
9Eric de Burbure111100+13.86%
10Dries Loncke111100+11.43%
11Rob Borghmans111100+10.64%
12Maarten Vandersteegen111100+9.67%
13Geert Denoo111100+9.52%
14Jonas Geuten111100+7.73%
15Geoffrey Restrebada Gonzalez111100+6.81%
16Maarten Van Cauwenberghe222100+6.17%
17Rudy Wasteels111100+6.15%
18Luc Cattrysse111100+6.13%
19Robert Dijkstra44375+5.03%
20Frank Verplancke111100+4.69%
21Ramon de Koning111100+4.13%
22Nicolas Friday111100+3.47%
23Tom De Smet111100+3.18%
24Simone Marticke111100+2.57%
25Kris Rens22150+1.81%
26Jens Engels111100+1.07%
27Andy Sermant111100+1.03%
28Jonas Smeets111100+0.78%
29Jan Coopman111100+0.67%
30Maxim Corbet11000%
31DIRK RONDAS11000%
32Marc Mommen22000%
33Nadine Baetens11000%
34Marc Vanderwegen11000%
35Peter Derison11000%
36Thierry Debus1100-0.18%
37Kristof Kimpen1100-0.31%
38William Demeyere1100-0.65%
39Joachim Snellings22150-0.88%
40Tony Hendrickx1100-0.94%
41sarah klinkhamers1100-1.13%
42Dirk Van de Wijgaert22150-1.28%
43Vasile Hupca1100-1.54%
44Michel Van Dosselaer22150-1.97%
45Guy Desmet1100-1.99%
46kris vermeir1000-2.31%
47Anton Naeyaert1100-2.53%
48Davy Janssen1100-2.56%
49Erikc Cor1100-3.25%
50Daniel Kutiriev1100-3.3%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BCART Comments

Write your thoughts about Biocartis Group NV
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Roel Munt
CrustyCrabz Nov 13, 2020 11:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
seems a risky one
Kim Maes
Kim Maes Nov 11, 2020 3:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Goeiemorgen, als je wil kopen onder de 5 is het nu de moment....
Kim Maes
Kim Maes Nov 10, 2020 6:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Big stock
Dimitri Tasevski
Dimitri Tasevski Sep 19, 2020 5:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock will go 200% high next week
Mark Swaelen
Mark Swaelen Sep 29, 2019 5:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
In what sense does Biocartis differ from Theranos of Elisabeth Holmes which was one big lie ?
Robbe Cobb
Cobb Sep 29, 2019 5:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Theranos never delivered peer reviewed research and wasn't transparent.. . . Biocartis has a lot of information available on their website.. . . I'm sure the Theranos scandal has hurt Biocartis' sales in the short term but I don't see how it will have an effect in the long term.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email